Effect of Erector Spinae Plane Block on Neuropathic Pain After Abdominal Hysterectomy
CompletedNot applicableNCT07830706
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study evaluated whether bilateral erector spinae plane block (ESPB) performed before abdominal hysterectomy could reduce postoperative pain and the development of chronic and neuropathic pain. Adult patients undergoing abdominal hysterectomy under general anesthesia were assigned to receive either bilateral ESPB with bupivacaine or standard perioperative analgesic management without ESPB. Postoperative pain was assessed during the early postoperative period and at 1 and 6 months after surgery. Chronic and neuropathic pain were evaluated at 1 and 6 months using validated pain assessment tools.
Study details
- Official title
- The Effect Of Erector Spinae Plane Block Performed In Abdominal Hysterectomy On Acute, Chronıc Postoperative and Neuropathic Pain: A Randomized Controlled Prospective Study
- Interventions
- Drug: Bupivacaine
- Other: Standard Perioperative Analgesia
- Sponsor
- Necmettin Erbakan University
- Start date
- 2025-01-01
- Primary completion
- 2025-12-31
- Sex
- Female
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adults aged 18-65 years * American Society of Anesthesiologists (ASA) physical status I-III * Body mass index (BMI) \<35 kg/m² * Scheduled for elective total abdominal hysterectomy under general anesthesia * Provided informed consent to participate in the study Exclusion Criteria: * Decompensated heart failure * Severe respiratory distress * Renal failure * Hepatic failure * History of opioid addiction * Current anticoagulant use or bleeding diathesis * Refusal to participate in the study
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07830706